U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004361) titled 'Ethical Issues of Using Gene Therapy in the Treatment of AMD' on May 26.
Brief Summary: The objective of this study is to examine the legitimacy of gene therapy use in the treatment of exudative age-related macular degeneration (AMD). This involves questioning its beneficence/non-maleficence ratio given the limited experience with this innovative technology and its irreversible effects, requiring a surgical procedure for administration. Additionally, the study explores patient autonomy in decision-making concerning complex therapeutic approaches and how patients should be supported to best uphold this autonomy.
Study Start Date: Jul...